#1
RANDOMIZED CONTROLLED TRIAL
Thomas R Abrahamsson, Ted Jakobsson, Malin Fagerås Böttcher, Mats Fredrikson, Maria C Jenmalm, Bengt Björkstén, Göran Oldaeus
BACKGROUND: An altered microbial exposure may underlie the increase of allergic diseases in affluent societies. Probiotics may alleviate and even prevent eczema in infants. OBJECTIVE: To prevent eczema and sensitization in infants with a family history of allergic disease by oral supplementation with the probiotic Lactobacillus reuteri. METHODS: Double-blind, randomized, placebo-controlled trial, which comprised 232 families with allergic disease, of whom 188 completed the study...
May 2007: Journal of Allergy and Clinical Immunology
1